These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population. Hernandez CC; Klassen TL; Jackson LG; Gurba K; Hu N; Noebels JL; Macdonald RL PLoS One; 2016; 11(9):e0162883. PubMed ID: 27622563 [TBL] [Abstract][Full Text] [Related]
10. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870 [TBL] [Abstract][Full Text] [Related]
11. Molecular and clinical descriptions of patients with GABA Maillard PY; Baer S; Schaefer É; Desnous B; Villeneuve N; Lépine A; Fabre A; Lacoste C; El Chehadeh S; Piton A; Porter LF; Perriard C; Wardé MA; Spitz MA; Laugel V; Lesca G; Putoux A; Ville D; Mignot C; Héron D; Nabbout R; Barcia G; Rio M; Roubertie A; Meyer P; Paquis-Flucklinger V; Patat O; Lefranc J; Gerard M; ; de Bellescize J; Villard L; De Saint Martin A; Milh M Epilepsia; 2022 Oct; 63(10):2519-2533. PubMed ID: 35718920 [TBL] [Abstract][Full Text] [Related]
13. A novel variant in GABRB2 associated with intellectual disability and epilepsy. Srivastava S; Cohen J; Pevsner J; Aradhya S; McKnight D; Butler E; Johnston M; Fatemi A Am J Med Genet A; 2014 Nov; 164A(11):2914-21. PubMed ID: 25124326 [TBL] [Abstract][Full Text] [Related]
14. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes. Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640 [TBL] [Abstract][Full Text] [Related]
16. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy. Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790 [TBL] [Abstract][Full Text] [Related]
17. Expanding the clinical phenotype and genetic spectrum of GEMIN5 disorders: Early-infantile developmental and epileptic encephalopathies. Zhang J; Liu X; Zhu G; Wan L; Liang Y; Li N; Huang M; Yang G Brain Behav; 2024 May; 14(5):e3535. PubMed ID: 38773790 [TBL] [Abstract][Full Text] [Related]
18. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy. Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442 [TBL] [Abstract][Full Text] [Related]
19. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype. Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403 [TBL] [Abstract][Full Text] [Related]